Medical Treatment of Benign Insulinoma Using Octreotide LAR: A Case Report-Reference-Cited by-同舟云学术

Medical Treatment of Benign Insulinoma Using Octreotide LAR: A Case Report

Published:2007 Issue:1 Volume:54 Page:95-101
ISSN:0918-8959
Container-title:Endocrine Journal
language:en
Short-container-title:Endocr J

Author:

USUKURA Mikiya¹,YONEDA Takashi¹,ODA Nobushige¹,YAMAMOTO Yasuhiro¹,TAKATA Hiroyuki¹,HASATANI Kenkou²,TAKEDA Yoshiyu¹

Affiliation:

1. Molecular Genetics of Cardiovascular Disorders, Graduate School of Medical Science, Kanazawa University

2. Department of Internal Medicine, Suzu Municipal General Hospital

Publisher

Japan Endocrine Society

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://www.jstage.jst.go.jp/article/endocrj/54/1/54_1_95/_pdf

Reference18 articles.

1. Use of long-acting somatostatin analog SMS 201-995 in patients with pancreatic islet cell tumors

2. 2. Stehouwer CDA, Lems WF, Fischer HRA, Hackeng WHL, Naafs MAB (1989) Aggravation of hypoglycemia in insulinoma patients by the long-acting somatostatin analogue octreotide (Sandostatin). Acta Endocrinol (Copenh) 121: 34-40.

3. The effectiveness of administering a minimal dose of octreotide long-term prior to surgery for insulinoma: Report of a case

4. 4. Hearn PR, Ahmed M, Woodhouse NJY (1988) The use of SMS 201-995 (somatostatin analogue) in insulinomas: Additional case report and literature review. Hormone Res 29: 211-213.

5. 5. Glaser B, Roesler A, Halperin Y (1990) Chronic treatment of a benign insulinoma using the long-acting somatostatin analogue SMS 201-995. Isr J Med Sci 26: 16-19.

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Somatostatin Analogs and Interferon in the Treatment of Neuroendocrine Tumors;Neuroendocrine Tumours;2024

2. Recent advances in diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms;World Journal of Gastrointestinal Surgery;2022-05-27

3. Varied presentations of pancreatic insulinoma: a case report;Pan African Medical Journal;2022

4. A case of malignant insulinoma responsive to somatostatin analogs treatment;BMC Endocrine Disorders;2018-12

5. Peptide receptor radionuclide therapy with 177Lu-DOTA-TATE as a promising treatment of malignant insulinoma: a series of case reports and literature review;Journal of Endocrinological Investigation;2018-06-09